Product Dossier
EZECREST COMPOSITE PACK
Product Dossier for EZECREST COMPOSITE PACK (ezetimibe, rosuvastatin, Pharmacor). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Pharmacor
- Active ingredient: ezetimibe, rosuvastatin
- Therapeutic area: Cardiology
- Related brand: ATOZET
- Related brand: APO-EZETIMIBE/SIMVASTATIN
- Related brand: ZETEZE
- Same area: OPSUMIT
- Same area: TARKA
What it is
EZECREST COMPOSITE PACK is a composite pack containing ezetimibe 10 mg tablets and rosuvastatin (as calcium) tablets for oral administration. The rosuvastatin component is available in strengths of 10 mg, 20 mg or 40 mg.
Regulatory history
EZECREST COMPOSITE PACK was first listed on the ARTG on 6 February 2023, with three registered variants: the 10 mg plus 10 mg combination (ARTG 375662), the 10 mg plus 20 mg combination (ARTG 375655), and the 10 mg plus 40 mg combination (ARTG 375670).